PLG acquires Outcomes'10, expanding its market access capabilities

ProductLife Group is pleased to announce the acquisition of Outcomes’10, a premier life sciences consultancy providing market access services, including pricing & reimbursement, health economics, and outcomes research, as well as real-world data generation. With a strategic location in the Scientific Park of Castellón, Spain, Outcomes’10 provides expert guidance across a wide range of therapeutic areas.
Read the press release here

ProductLife Group is proud to present its 2023 Sustainability Report

In the foreword to the report, CEO Xavier Duburcq highlights some of our greatest achievements in 2023 – including our commitment to the Science Based Targets initiative, reducing our attrition rates, and reaching 48% women in management globally. You’ll also find all of our sustainability targets and progress towards meeting our goals. Finally, we’ve included a note from our CSR Steering Committee regarding the future of sustainability at PLG.
Check out the report

Re-Energizing for our Growth Plan

The PLG’s leadership team thoroughly enjoyed its recent gathering in Prague, to re-energize in the perspective of PLG’s 2028 ambition and of course the final sprint of the year. This ‘pit stop’ was an invaluable opportunity to step back from daily routines and reconnect with PLG’s core values of team spirit, positive leadership, continuous improvement, and entrepreneurship. It was also a time filled with fun and great moments together.
About us

A Special Visit from our Executive Committee

This week, ’s Prague Office had the honor of hosting our EXCO team: Xavier Duburcq, our CEO; Christophe Richarme, our CFO; Candice Bosson, our CPO and Charlène TRAVERS-CHEVALIER., our CCO. It was a fantastic opportunity to showcase the incredible work we’re doing and reflect on the values that unite us as a company: Teamwork, Diversity, Continuous Improvement, Entrepreneurial Mindset.
All about our core values

Another year of successful 10KM Run for a greater cause

Last Saturday, our amazing PLG team joined 4,800 runners in Prague for a thrilling 10km Birell race, embracing the values of fitness, fun, and teamwork. Colleagues from the Prague office joined forces with members of LT team, and the effort from our runners was simply inspiring!
We’re also proud to have run in support of Het Leontienhuis, a fantastic organization providing care for those affected by eating disorders. There’s still time to make a difference.

Support the cause here

Membership

At ProductLife Group (PLG), we are dedicated to delivering innovative solutions for our clients and partners in the life sciences industry. Our active memberships and associations with key global organizations enable us to leverage a vast network of expertise, from product development, lifecycle management, HEOR, digital transformation, quality, to innovation. These valuable connections enable us to remain at the forefront of industry progress, guaranteeing that we continuously elevate the impact we deliver to our clients, partners, and, most importantly, patients on a global scale.

Discover our services

The Boom of the Recent Nearshoring in LATAM: New Opportunities Ahead

Following up on our previous article on biosimilars in LATAM, our next segment regarding the LATAM market takes a deeper look into the boom of the recent nearshoring in LATAM. This article provides a broad overview of why nearshoring is becoming popular in LATAM and what opportunities can arise from this effect for the pharma companies and the LATAM community. Our goal at is to be able to provide guidance to medical companies with their expansion into new markets and to supply globalized solutions for process and resource optimization.

 

Experience the global reach of PLG here

New Era in Gene Therapy and Cancer Treatment

The FDA’s approval of Tecelra marks a breakthrough in the evolution of gene therapy. This groundbreaking treatment harnesses the body’s immune system to target and destroy cancer cells, offering hope to patients with metastatic synovial sarcoma. Tecelra’s approval highlights the potential of gene therapy to revolutionize cancer treatment. However, developing complex therapies involves significant challenges, including navigating a complex regulatory landscape, investing in robust clinical trial design, and fostering strong industry collaborations.

As the field continues to advance, addressing these challenges will be essential for bringing more life-saving gene therapies to patients.

 

Learn how PLG can support your gene therapy journey

Register to our news and events

Go to our Events to register
Go to our News to get insights

See all our news and events
September 2024 Monthly Newsletter